ZA831390B - Cephalosporin compounds - Google Patents

Cephalosporin compounds

Info

Publication number
ZA831390B
ZA831390B ZA831390A ZA831390A ZA831390B ZA 831390 B ZA831390 B ZA 831390B ZA 831390 A ZA831390 A ZA 831390A ZA 831390 A ZA831390 A ZA 831390A ZA 831390 B ZA831390 B ZA 831390B
Authority
ZA
South Africa
Prior art keywords
cephalosporin compounds
cephalosporin
compounds
Prior art date
Application number
ZA831390A
Other languages
English (en)
Inventor
Aburaki Shimpei
Kamachi Hajime
Narita Yukio
Okumura Jun
Naito Takayuki
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ZA831390B publication Critical patent/ZA831390B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA831390A 1982-03-04 1983-03-01 Cephalosporin compounds ZA831390B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/354,851 US4406899A (en) 1982-03-04 1982-03-04 Cephalosporins

Publications (1)

Publication Number Publication Date
ZA831390B true ZA831390B (en) 1984-02-29

Family

ID=23395168

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA831390A ZA831390B (en) 1982-03-04 1983-03-01 Cephalosporin compounds

Country Status (4)

Country Link
US (1) US4406899A (fr)
JP (1) JPS58174387A (fr)
SU (1) SU1303029A3 (fr)
ZA (1) ZA831390B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
EP0053893B1 (fr) * 1980-12-09 1985-03-20 Beecham Group Plc Dérivés de l'acide clavulanique, leur préparation et leur application
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
GB8410000D0 (en) * 1984-04-17 1984-05-31 Fujisawa Pharmaceutical Co Cephem compounds
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
EP0182210B1 (fr) * 1984-11-12 1991-02-27 Banyu Pharmaceutical Co., Ltd. Dérivés de céphalosporine
JPH06104674B2 (ja) * 1984-11-12 1994-12-21 萬有製薬株式会社 新規セフアロスポリン誘導体
JPH06102668B2 (ja) * 1985-08-06 1994-12-14 萬有製薬株式会社 新規セフアロスポリン誘導体
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
CA1267647A (fr) * 1984-12-27 1990-04-10 Ryosuke Ushijima Derives de cephalosporine
US4698336A (en) * 1985-01-30 1987-10-06 Eisai Co., Ltd. 3-(pyrrolidinio)methyl-3-cephem derivatives
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
FR2585705B1 (fr) * 1985-08-05 1989-01-13 Bristol Myers Co Sels de cephalosporine et compositions injectables
AT393452B (de) * 1985-08-05 1991-10-25 Bristol Myers Squibb Co Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
US4659812A (en) * 1985-08-20 1987-04-21 Bristol-Myers Company Cephalosporin intermediates
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
US4680389A (en) * 1986-01-10 1987-07-14 Bristol-Myers Company Temperature stable crystalline di(1-methyl-2-pyrralidinone) and di(N-formylpyrrolidine) adducts of cephalosporin derivatives
EP0237735B1 (fr) * 1986-03-17 1994-03-30 Fujisawa Pharmaceutical Co., Ltd. Dérivés 3,7-disubstitués-3-céphem et procédé pour leur préparation
US4814328A (en) * 1986-03-19 1989-03-21 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives, and antibacterial agents
CA1296012C (fr) 1986-03-19 1992-02-18 Susumu Nakagawa Derives de 6,7-dihydroxy-isoquinaline
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
CA2011116C (fr) * 1989-03-06 1999-11-16 Murray A. Kaplan Dihydrochlorure de bmy-28142 lyophilise pour usage parenteral
US6248881B1 (en) 1991-03-08 2001-06-19 Biochemie Gmbh Intermediates and process for the production of 3-vinyl cephalosporins
US5594129A (en) * 1991-09-10 1997-01-14 Bristol-Myers Squibb Company Process for the preparation of a cephalosporin antibiotic
US5698703A (en) * 1991-09-10 1997-12-16 Bristol-Myers Squibb Company Syn-isomer of thiazolyl intermediate and process for the preparation thereof
CA2099692C (fr) * 1992-07-24 2003-09-30 Gary M. F. Lim Procede de preparation d'intermediaires de la cephalosporine
CA2101571A1 (fr) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Dihydrate cristallise d'un sel de cephalosporine dihydrate; compositions injectables a base de ce compose
US5391729A (en) * 1992-09-08 1995-02-21 Bristol-Myers Squibb Company Crystalline dihydrate of a cephalosporin salt
US5401842A (en) * 1992-09-08 1995-03-28 Bristol-Myers Squibb Company Injectable compositions of a cephalosporin dihydrate salt
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics
JP2723088B2 (ja) * 1994-09-07 1998-03-09 藤沢薬品工業株式会社 セファロスポリン化合物の新規な結晶
US5686588A (en) * 1995-08-16 1997-11-11 Yoo; Seo Hong Amine acid salt compounds and process for the production thereof
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
EP1618114B1 (fr) 2003-04-16 2010-07-14 Sandoz AG Procedes de preparation de cefepime
ES2298850T3 (es) * 2003-12-23 2008-05-16 Sandoz Gmbh Proceso para la produccion de intermedios para utilizar en la sintesis de la cefalosporina.
CN100396688C (zh) * 2004-05-20 2008-06-25 江苏恒瑞医药股份有限公司 头孢烯类化合物磷酸酯及其制备方法和用途
WO2006008749A1 (fr) * 2004-07-16 2006-01-26 Hetero Drugs Limited Procede de preparation d'intermediaires de cephalosporine pures
EP2015755A4 (fr) * 2006-04-28 2010-02-24 Wockhardt Ltd Traitement amélioré pour traiter des infections bactériennes résistantes
CN101210023B (zh) * 2006-12-30 2010-12-08 山东轩竹医药科技有限公司 一种头孢菌素衍生物
JPWO2013051597A1 (ja) * 2011-10-04 2015-03-30 塩野義製薬株式会社 カテコール基を有するセフェム誘導体
JP6967000B2 (ja) * 2015-12-10 2021-11-17 ナエジャ−アールジーエム ファーマシューティカルズ ユーエルシー セフェム系化合物、それらの生成および使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
GB1591439A (en) * 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
JPS53103493A (en) 1977-02-18 1978-09-08 Takeda Chem Ind Ltd Cephalosporin derivatives and process for their preparation
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
JPS5566591A (en) * 1978-11-15 1980-05-20 Glaxo Group Ltd Cephalosporin antibiotic

Also Published As

Publication number Publication date
SU1303029A3 (ru) 1987-04-07
JPS58174387A (ja) 1983-10-13
JPH0326197B2 (fr) 1991-04-10
US4406899A (en) 1983-09-27

Similar Documents

Publication Publication Date Title
ZA831390B (en) Cephalosporin compounds
GB2120248B (en) Polypiperidine compounds
GB2104888B (en) Cephalosporin compounds
ZA832156B (en) Cephalosporin compounds
GB8324081D0 (en) Cephem compounds
GB8331713D0 (en) Cephem compounds
GB2116180B (en) Cephalosporin derivatives
DE3362221D1 (en) Azolylstyryl compounds
GB8330745D0 (en) Cephem compounds
DE3368638D1 (en) Cephalosporin derivatives
DE3364273D1 (en) Dioxocyclobutene compounds
GB2128200B (en) Chloro-triazinyl mondazo compounds
GB2131800B (en) Cephalosporins
GB2131799B (en) Cephalosporin compounds
DE3380813D1 (en) Cephalosporin derivatives
DE3379404D1 (en) Cephalosporin derivatives
ZA834759B (en) Cephalosporin compounds
IL63767A0 (en) Cephalosporin compounds
GB2125033B (en) Cephalosporins
DE3379464D1 (en) Cephalosporin derivatives
IE822361L (en) Cephalosporin compounds
PH19163A (en) Cephalosporin derivatives
ZA831887B (en) Cephalosporin derivatives
PH16811A (en) Cephalosporin
IE822600L (en) Cephalosporin